Lista de obras - Alain Gadisseur - Dominio Público Uruguay

A critical appraisal of non-invasive diagnosis and exclusion of deep vein thrombosis and pulmonary embolism in outpatients with suspected deep vein thrombosis or pulmonary embolism: how many tests do we need?

artículo científico publicado en 2005

A novel HLA-C null allele, HLA-C*05:99N

artículo científico publicado en 2014

A warning about agranulocytosis with the use of cocaine adulterated with levamisole.

artículo científico publicado en 2011

An observational efficacy and safety analysis of the treatment of acute invasive aspergillosis using voriconazole

artículo científico publicado en 2011

Aspirin-responsive, migraine-like transient cerebral and ocular ischemic attacks and erythromelalgia in JAK2-positive essential thrombocythemia and polycythemia vera

artículo científico publicado en 2014

Clinical and microbiological impact of discontinuation of fluoroquinolone prophylaxis in patients with prolonged profound neutropenia

artículo científico publicado en 2014

Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders.

artículo científico publicado en 2012

Comparison of control and stability of oral anticoagulant therapy using acenocoumarol versus phenprocoumon.

artículo científico publicado en 2003

Dominant von Willebrand disease type 2M and 2U are variable expressions of one distinct disease entity caused by loss-of-function mutations in the A1 domain of the von Willebrand factor gene

artículo científico publicado en 2009

Essential differences in clinical and bone marrow features in BCR/ABL-positive thrombocythemia compared to thrombocythemia in the BCR/ABL-negative myeloproliferative neoplasms essential thrombocythemia and polycythemia vera.

artículo científico publicado en 2014

Identification of a novel candidate splice site mutation (0874 + 1G > A) in a type 3 von Willebrand disease patient

scientific article published on 01 August 2007

Induction of complete and molecular remissions in acute myeloid leukemia by Wilms' tumor 1 antigen-targeted dendritic cell vaccination

artículo científico publicado en 2010

Laboratory and molecular characteristics of recessive von Willebrand disease type 2C (2A subtype IIC) of variable severity due to homozygous or double heterozygous mutations in the D1 and D2 domains

artículo científico publicado en 2009

Laboratory diagnosis and molecular basis of mild von Willebrand disease type 1.

scientific article published on 08 June 2009

Laboratory diagnosis and molecular classification of von Willebrand disease

artículo científico publicado en 2009

Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the v

scientific article published on 08 June 2009

Long-term epidemiology of bacterial susceptibility profiles in adults suffering from febrile neutropenia with hematologic malignancy after antibiotic change.

artículo científico publicado en 2010

Managing patients with von Willebrand disease type 1, 2 and 3 with desmopressin and von Willebrand factor-factor VIII concentrate in surgical settings

artículo científico publicado en 2009

Medical and surgical management of paraneoplastic pyoderma gangrenosum--a case report and review of the literature.

artículo científico publicado en 2010

Multiplate whole blood impedance aggregometry: a recent experience

artículo científico publicado en 2008

Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life.

artículo científico publicado en 2004

Phialemonium curvatum fungaemia in an immunocompromised patient: case report.

artículo científico publicado en 2011

Recessive von Willebrand disease type 2 Normandy: variable expression of mild hemophilia and VWD type 1.

artículo científico publicado en 2009

Self-monitoring of oral anticoagulation: systematic review and meta-analysis of individual patient data

artículo científico publicado en 2012

Sensitization to the mammalian oligosaccharide galactose-alpha-1,3-galactose (alpha-gal): experience in a Flemish case series.

artículo científico publicado en 2013

Successful pregnancy in a patient with factor V deficiency: case report and review of the literature

artículo científico publicado en 2006

The influence of laboratory-induced MELD score differences on liver allocation: more reality than myth.

artículo científico publicado en 2011

The quality of oral anticoagulant therapy and recurrent venous thrombotic events in the Leiden Thrombophilia Study.

artículo científico publicado en 2007

Therapeutic quality control of oral anticoagulant therapy comparing the short-acting acenocoumarol and the long-acting phenprocoumon.

artículo científico publicado en 2002

Lista de obras de Alain Gadisseur

A critical appraisal of non-invasive diagnosis and exclusion of deep vein thrombosis and pulmonary embolism in outpatients with suspected deep vein thrombosis or pulmonary embolism: how many tests do we need?

A novel HLA-C null allele, HLA-C*05:99N

A warning about agranulocytosis with the use of cocaine adulterated with levamisole.

An observational efficacy and safety analysis of the treatment of acute invasive aspergillosis using voriconazole

Aspirin-responsive, migraine-like transient cerebral and ocular ischemic attacks and erythromelalgia in JAK2-positive essential thrombocythemia and polycythemia vera

Clinical and microbiological impact of discontinuation of fluoroquinolone prophylaxis in patients with prolonged profound neutropenia

Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders.

Comparison of control and stability of oral anticoagulant therapy using acenocoumarol versus phenprocoumon.

Dominant von Willebrand disease type 2M and 2U are variable expressions of one distinct disease entity caused by loss-of-function mutations in the A1 domain of the von Willebrand factor gene

Essential differences in clinical and bone marrow features in BCR/ABL-positive thrombocythemia compared to thrombocythemia in the BCR/ABL-negative myeloproliferative neoplasms essential thrombocythemia and polycythemia vera.

Identification of a novel candidate splice site mutation (0874 + 1G > A) in a type 3 von Willebrand disease patient

Induction of complete and molecular remissions in acute myeloid leukemia by Wilms' tumor 1 antigen-targeted dendritic cell vaccination

Laboratory and molecular characteristics of recessive von Willebrand disease type 2C (2A subtype IIC) of variable severity due to homozygous or double heterozygous mutations in the D1 and D2 domains

Laboratory diagnosis and molecular basis of mild von Willebrand disease type 1.

Laboratory diagnosis and molecular classification of von Willebrand disease

Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the v

Long-term epidemiology of bacterial susceptibility profiles in adults suffering from febrile neutropenia with hematologic malignancy after antibiotic change.

Managing patients with von Willebrand disease type 1, 2 and 3 with desmopressin and von Willebrand factor-factor VIII concentrate in surgical settings

Medical and surgical management of paraneoplastic pyoderma gangrenosum--a case report and review of the literature.

Multiplate whole blood impedance aggregometry: a recent experience

Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life.

Phialemonium curvatum fungaemia in an immunocompromised patient: case report.

Recessive von Willebrand disease type 2 Normandy: variable expression of mild hemophilia and VWD type 1.

Self-monitoring of oral anticoagulation: systematic review and meta-analysis of individual patient data

Sensitization to the mammalian oligosaccharide galactose-alpha-1,3-galactose (alpha-gal): experience in a Flemish case series.

Successful pregnancy in a patient with factor V deficiency: case report and review of the literature

The influence of laboratory-induced MELD score differences on liver allocation: more reality than myth.

The quality of oral anticoagulant therapy and recurrent venous thrombotic events in the Leiden Thrombophilia Study.

Therapeutic quality control of oral anticoagulant therapy comparing the short-acting acenocoumarol and the long-acting phenprocoumon.